Терапевтическая инертность как причина неконтролируемой артериальной гипертонии в амбулаторной практике: результаты исследования АРГУС-2

1. Профилактика, диагностика и лечение артериальной гипертензии. Российские рекомендации (второй пересмотр). Кардиваскулярная терапия и профилактика, приложение. 2004;с.20.

2.

3. Chobanian A.V., Bakris G.L., Black H.R. et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.

4.

5. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992.

6.

7. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.

8.

9. Okonofua EC et al. Hypertension. 2006; 47:345-351.

10.

11. Fine L.J., Cutler J.A. Hypertension. 2006; 47:319-320.

12.

13. Hansson L., Zanchetti A., Carruthers S.G. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet.l998;351:1755-1762.

14.

15. Psaty B.M., Lumley Т., Furberg C.D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-2544

16.

17. Kostis J.B., Wilson A.C. Fredenberger R.S. et al. Long- term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95:29-35.

18.

19. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165:1410-1419.

20.

21. Moser M. Diuretics should continue to be one of the preferred initial therapies in the management of hypertension. The argument for. J Clin Hypertens. 2005;7:111-116

22.

23. PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl). 1995;108:710-717.

24.

25. Gosse P., Sheridan P., Zannad F.al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens. 2000;18:1465-1475.

26.

27. Marre M., Puig J.G., Kokot F. et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. J Hypertens. 2004;22:1613-1622.

28.

29. London G., Schmiede R., Calvo C. Antihypertensive efficacy of indapamide SR vs candesartan and amlodipine in hypertensive patients: the X-cellent main study J Hypertens 2004;22 (suppl.2):S384 S1 13.

30.

31. London G., Schmiede R., Calvo C. Indapamide SR antihypertensive efficacy vs candesartan and amlodipine in isolated systolic hypertensive patients: the X-cellent ISH substudy. J Hypertens 2004;22 (suppl.2):S384 S1 13.

32.